Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Hormone Replacement Therapy	NCIT_C15599	[Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.]
Replacement Therapy	NCIT_C15471	[Administration of a body substance to compensate for the loss, as from disease or surgery, of a gland or tissue that would normally produce the substance.]
Endocrine Drug Therapy	NCIT_C63475
Phase I Trial	NCIT_C15600	[A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects.]
Clinical Study by Phase	NCIT_C70820
Phase IV Trial	NCIT_C15603	[A randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed.]
Chemoprevention	NCIT_C15604	[The use of natural or synthetic substances (e.g., drugs, vitamins, hormones, plant products) or food supplements to reduce the risk of developing a disease, to reduce the chance that disease will recur, or to delay the recurrence.]
Nutrition, Trace Elements	NCIT_C15605	[Role of trace elements in cancer causation or prevention and in general health.]
Nutrition, Dietary Components	NCIT_C15824	[Role of dietary components in cancer causation or prevention and in general health.]
Acupressure Therapy	NCIT_C15606	[The application of non-invasive finger pressure along energy points throughout the body in order to relieve pain and induce a feeling of well-being.]
Alternative Medical Procedure	NCIT_C64386	[Treatment used instead of, or supplementary to, conventional Western-based practices. Alternative medicine includes treatments and practices such as acupuncture, holistic medicine, homeopathy, ayurveda, Chinese medicine, massage therapy, herbal therapy, and biofeedback.]
Clinical Diagnosis	NCIT_C15607	[A diagnosis made from a study of the signs and symptoms of a disease.]
Diagnosis	NCIT_C15220	[The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.]
Staging	NCIT_C15608	[The process of defining at what point in the natural history of a malignant disease a patient is when a diagnosis is made.]
Anastomosis	NCIT_C15609	[A natural or surgically-induced connection between tubular structures in the body.]
Aspirin/Interferon Alfa	NCIT_C15610
Recombinant Interferon Alfa	NCIT_C225	[A class of naturally-isolated or recombinant therapeutic peptides used as antiviral and anti-tumor agents. Alpha interferons are cytokines produced by nucleated cells (predominantly natural killer (NK) leukocytes) upon exposure to live or inactivated virus, double-stranded RNA or bacterial products. These agents bind to specific cell-surface receptors, resulting in the transcription and translation of genes containing an interferon-specific response element. The proteins so produced mediate many complex effects, including antiviral effects (viral protein synthesis); antiproliferative effects (cellular growth inhibition and alteration of cellular differentiation); anticancer effects (interference with oncogene expression); and immune-modulating effects (natural killer cell activation, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity). (NCI04)]
Aspirin	NCIT_C287	[An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acetylates serine residues in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation. This agent exhibits analgesic, antipyretic, and anticoagulant properties.]
Interferon Alfa/Monoclonal Antibody CC49	NCIT_C15611
Minretumomab	NCIT_C2567	[A second-generation murine monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells. (NCI04)]